Testing effectiveness (Phase 2)Study completedNCT03192202What this trial is testingAFM13 in Relapsed/Refractory Cutaneous LymphomasWho this might be right forLymphoma, T-Cell, Cutaneous Ahmed Sawas 18
Early research (Phase 1)Ended earlyNCT00671112What this trial is testingEverolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaWho this might be right for714leukemiaLymphoma Brian Hill, MD, PhD 30
Testing effectiveness (Phase 2)Study completedNCT00888927What this trial is testingSafety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell LymphomaWho this might be right forPeripheral T-Cell Lymphoma Kyowa Kirin Co., Ltd. 42
Early research (Phase 1)WithdrawnNCT02757248What this trial is testingPh1 Volasertib Plus Romidepsin in R/R PTCL and CTCLWho this might be right forPTCLCTCL Anne Beaven, MD
Testing effectiveness (Phase 2)Study completedNCT02106650What this trial is testingPhase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological MalignanciesWho this might be right forRelapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma Acrotech Biopharma Inc. 36
Early research (Phase 1)Study completedNCT05225584What this trial is testingSafety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid TumorsWho this might be right forNon Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more Kymera Therapeutics, Inc. 56
Early research (Phase 1)Study completedNCT02567656What this trial is testingSafety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell LymphomaWho this might be right forLymphoma, T-Cell, PeripheralLymphoma, T-Cell, Cutaneous Rhizen Pharmaceuticals SA 58
Early research (Phase 1)Study completedNCT02512497What this trial is testingRomidepsin Maintenance After Allogeneic Stem Cell TransplantationWho this might be right forCutaneous T-cell LymphomaT-Prolymphocytic LeukemiaT-Large Granulocytic Leukemia+2 more Ohio State University Comprehensive Cancer Center 23
Early research (Phase 1)Looking for participantsNCT04234048What this trial is testingPhase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaWho this might be right forT-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell Lymphoma+8 more SciTech Development, Inc. 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07758491What this trial is testingA Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell LymphomaWho this might be right forPTCLTRBC1 ADCCTCL FutureGen Biopharmaceutical (Beijing) Co., Ltd 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT06485219What this trial is testingA Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell LymphomaWho this might be right forRelapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Cutaneous T-cell Lymphoma (CTCL) Chengdu Zenitar Biomedical Technology Co., Ltd 50
Early research (Phase 1)Looking for participantsNCT07192471What this trial is testingA First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaWho this might be right forT-cell NHL (PTCL or CTCL) Kyowa Kirin, Inc. 72
Early research (Phase 1)Looking for participantsNCT07055477What this trial is testingA Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)Who this might be right forRelapsed and/or Refractory Mature T Cell MalignancyPeripheral T-Cell LymphomaAngioimmunoblastic T-cell Lymphoma+7 more National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT02520791What this trial is testingAnti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell LymphomaWho this might be right forAdvanced Primary Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeRecurrent Grade 1 Follicular Lymphoma+16 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05475925What this trial is testingDR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasWho this might be right forLGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell LymphomaPrimary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma+10 more Dren Bio 200
Testing effectiveness (Phase 2)Temporarily pausedNCT05138458What this trial is testingMT-101 in Subjects With CD5+ Relapsed/Refractory TCLWho this might be right forLymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousMycosis Fungoides+2 more Myeloid Therapeutics 40
Early research (Phase 1)Active Not RecruitingNCT02732275What this trial is testingDS-3201b in Participants With LymphomasWho this might be right forLymphoma, MalignantNon-hodgkin Lymphoma Daiichi Sankyo Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT01226472What this trial is testingExtension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001Who this might be right forPeripheral T-cell LymphomaCutaneous T-cell Lymphoma Kyowa Kirin Co., Ltd. 1
Testing effectiveness (Phase 2)Study completedNCT03493451What this trial is testingStudy of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell NeoplasmsWho this might be right forPeripheral T Cell LymphomaPTCLExtranodal NK/T-cell Lymphoma+16 more BeiGene 77
Testing effectiveness (Phase 2)Study completedNCT02232516What this trial is testingRomidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+14 more Northwestern University 30